Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017-2022.
Oriana CianiMichela MeregagliaMario Alberto BattagliaGianpaolo BrichettoAntonella ConteClaudio GasperiniValeria SansonePublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Compared to other disease areas, neurology is one where the use of patient-reported outcomes evidence is inherently part of the clinical evaluation and for which core outcome sets exist. Better harmonization of the instruments recommended for use would facilitate the consideration of PROMs at all stages in the drug development process.